EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Discovery the Mechanism of Qingdi Mixture for Radiation‐Induced Lung Injury Based on Network Pharmacology, Clinical Retrospective Analysis and Experimental Validation

Haoran Liu iD, Zhuang Yu, Qiancheng Lu, Yuke Mao, Qingzheng Liu, Shengnan Ren, Miao Zhang, Hongzong Si, Jing Wang iD

Thoracic Cancer · 2025-10 · 16 (19)

DOI: 10.1111/1759-7714.70171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 10.10.2025. Verfasst von Haoran Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Network Pharmacology, Drugs, Chinese Herbal, Lung Injury, Radiation Injuries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shandong Province Natural Science Foundation of China, Wu Jieping Medical Foundation, Beijing Xisike Clinical Oncology Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiation‐induced lung injury (RILI) can be caused by thoracic tumor radiotherapy. Qingdi mixture (QDM) has been routinely used in preventing RILI during tumor radiotherapy. However, the molecular mechanisms of QDM remain to be fully elucidated. Initially, we employed network pharmacology to identify potential therapeutic targets and their related signaling pathways. Secondly, molecular docking was applied to validate the interactions between the QDM components and hub targets. Furthermore, we retrospectively collected clinical data from RILI patients who received basic therapy combined with QDM. To investigate the therapeutic potential, we established both in vitro RILI cell models and in vivo murine models. We elucidated the molecular mechanisms of QDM's protective effects against RILI. The network pharmacology results showed that 157 common targets were identified for RILI. Enrichment analysis indicated that NF‐κB, JAK‐STAT, and necroptosis signaling pathways were involved in the QDM treatment of RILI. The molecular docking results indicated that ligands from multiple compounds exhibited strong interactions with inflammatory cytokines, including IL‐6, IL‐1α, IL‐4, and so on. The therapeutic efficacy of QDM was verified by clinical observation of patients with RILI. In vitro experiments demonstrate that QDM promotes cell proliferation after radiation therapy. Meanwhile, in vivo experiments showed that QDM reduced inflammatory factor levels and enhanced the therapeutic effects of basic treatment. Finally, the western blot experiments were conducted to verify the activation of the NF‐κB signaling pathway, as predicted by network pharmacology. This study demonstrated that QDM effectively alleviates RILI and holds promise for broad clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Network PharmacologyDrugs, Chinese HerbalLung InjuryRadiation InjuriesHumansAnimalsMiceRetrospective StudiesMaleFemaleMolecular Docking Simulation

Stichwörter der Autor:innen

NF‐κBQingdi mixturemolecular dockingnetwork pharmacologyradiation therapyradiation‐induced lung injury

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • The Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • The Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • State Key Laboratory of bio-Fibers and eco-Textiles, Qingdao University, Qingdao, Shandong, China.

ORCID-Profile: Haoran Liu, Jing Wang

Förderung

  • Shandong Province Natural Science Foundation of China
  • Wu Jieping Medical Foundation
  • Beijing Xisike Clinical Oncology Research Foundation

Zitieren

APA

Liu, H., Yu, Z., Lu, Q., Mao, Y., Liu, Q., Ren, S., Zhang, M., Si, H., & Wang, J. (2025). Discovery the Mechanism of Qingdi Mixture for Radiation‐Induced Lung Injury Based on Network Pharmacology, Clinical Retrospective Analysis and Experimental Validation. Thoracic Cancer, 16(19). https://doi.org/10.1111/1759-7714.70171

Vancouver

Liu H, Yu Z, Lu Q, Mao Y, Liu Q, Ren S, et al. Discovery the Mechanism of Qingdi Mixture for Radiation‐Induced Lung Injury Based on Network Pharmacology, Clinical Retrospective Analysis and Experimental Validation. Thoracic Cancer. 2025;16(19). doi:10.1111/1759-7714.70171

BibTeX
@article{Liu2025,
  author = {Liu, Haoran and Yu, Zhuang and Lu, Qiancheng and Mao, Yuke and Liu, Qingzheng and Ren, Shengnan and Zhang, Miao and Si, Hongzong and Wang, Jing},
  title = {Discovery the Mechanism of Qingdi Mixture for Radiation‐Induced Lung Injury Based on Network Pharmacology, Clinical Retrospective Analysis and Experimental Validation},
  journal = {Thoracic Cancer},
  year = {2025},
  volume = {16},
  number = {19},
  doi = {10.1111/1759-7714.70171}
}
Kostenlos starten →